Clinical Research Directory

Inclusion Criteria: Patients: 1. Ability to understand and willingness to sign an IRB-approved informed consent 2. Age ≥ 18 years at the time of consent 3. Scheduled to undergo CAR-T therapy in the outpatient setting at AHWFBCCC 4. Ability to read and understand the English and/or Spanish language 5. As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study 6. Access to a mobile device for the duration of the trial Provider/Staff: Provider/staff participants must meet all of the following inclusion criteria to participate in the study: 1. Verbally agree to participate 2. Hospital at Home outpatient provider/advanced practice provider/nurse of at least one patient participant enrolled on Arm A who completed 14 days of temperature monitoring Exclusion Criteria: Patients: 1. Planned prophylactic tocilizumab for mitigation of CRS as documented in the clinical trials pathway submission 2. History of silicone allergy 3. History of Medical Adhesive-Related Skin Injury (MARSI) 4. Known skin condition that might preclude safe application of the patch, in the opinion of the enrolling investigator Provider/Staff: None